Epilepsy surgery trends in the United States, 1990―2008
To examine national time trends of resective surgery for the treatment of medically refractory epilepsy before and after Class I evidence demonstrating its efficacy and subsequent practice guidelines recommending early surgical evaluation. We performed a population-based cohort study with time trend...
Saved in:
Published in: | Neurology Vol. 78; no. 16; pp. 1200 - 1206 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Hagerstown, MD
Lippincott Williams & Wilkins
17-04-2012
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | To examine national time trends of resective surgery for the treatment of medically refractory epilepsy before and after Class I evidence demonstrating its efficacy and subsequent practice guidelines recommending early surgical evaluation.
We performed a population-based cohort study with time trends of patients admitted to US hospitals for medically refractory focal epilepsy between 1990 and 2008 who did or did not undergo lobectomy, as reported in the Nationwide Inpatient Sample.
Weighted data revealed 112,026 hospitalizations for medically refractory focal epilepsy and 6,653 resective surgeries (lobectomies and partial lobectomies) from 1990 to 2008. A trend of increasing hospitalizations over time was not accompanied by an increase in surgeries, producing an overall trend of decreasing surgery rates (F = 13.6, p < 0.01). Factors associated with this trend included a decrease in epilepsy hospitalizations at the highest-volume epilepsy centers, and increased hospitalizations to lower-volume hospitals that were found to be less likely to perform surgery. White patients were more likely to have surgery than racial minorities (relative risk [RR], 1.13; 95% confidence interval [CI], 1.10-1.17), and privately insured individuals were more likely to receive lobectomy than those with Medicaid or Medicare (RR, 1.28; 95% CI, 1.25-1.30).
Despite Class I evidence and subsequent practice guidelines, the utilization of lobectomy has not increased from 1990 to 2008. Surgery continues to be heavily underutilized as a treatment for epilepsy, with significant disparities by race and insurance coverage. Patients who are medically refractory after failing 2 antiepileptic medications should be referred to a comprehensive epilepsy center for surgical evaluation. |
---|---|
AbstractList | OBJECTIVETo examine national time trends of resective surgery for the treatment of medically refractory epilepsy before and after Class I evidence demonstrating its efficacy and subsequent practice guidelines recommending early surgical evaluation. METHODSWe performed a population-based cohort study with time trends of patients admitted to US hospitals for medically refractory focal epilepsy between 1990 and 2008 who did or did not undergo lobectomy, as reported in the Nationwide Inpatient Sample. RESULTSWeighted data revealed 112,026 hospitalizations for medically refractory focal epilepsy and 6,653 resective surgeries (lobectomies and partial lobectomies) from 1990 to 2008. A trend of increasing hospitalizations over time was not accompanied by an increase in surgeries, producing an overall trend of decreasing surgery rates (F = 13.6, p < 0.01). Factors associated with this trend included a decrease in epilepsy hospitalizations at the highest-volume epilepsy centers, and increased hospitalizations to lower-volume hospitals that were found to be less likely to perform surgery. White patients were more likely to have surgery than racial minorities (relative risk [RR], 1.13; 95% confidence interval [CI], 1.10-1.17), and privately insured individuals were more likely to receive lobectomy than those with Medicaid or Medicare (RR, 1.28; 95% CI, 1.25-1.30). CONCLUSIONDespite Class I evidence and subsequent practice guidelines, the utilization of lobectomy has not increased from 1990 to 2008. Surgery continues to be heavily underutilized as a treatment for epilepsy, with significant disparities by race and insurance coverage. Patients who are medically refractory after failing 2 antiepileptic medications should be referred to a comprehensive epilepsy center for surgical evaluation. Objective: To examine national time trends of resective surgery for the treatment of medically refractory epilepsy before and after Class I evidence demonstrating its efficacy and subsequent practice guidelines recommending early surgical evaluation. Methods: We performed a population-based cohort study with time trends of patients admitted to US hospitals for medically refractory focal epilepsy between 1990 and 2008 who did or did not undergo lobectomy, as reported in the Nationwide Inpatient Sample. Results: Weighted data revealed 112,026 hospitalizations for medically refractory focal epilepsy and 6,653 resective surgeries (lobectomies and partial lobectomies) from 1990 to 2008. A trend of increasing hospitalizations over time was not accompanied by an increase in surgeries, producing an overall trend of decreasing surgery rates (F = 13.6, p < 0.01). Factors associated with this trend included a decrease in epilepsy hospitalizations at the highest-volume epilepsy centers, and increased hospitalizations to lower-volume hospitals that were found to be less likely to perform surgery. White patients were more likely to have surgery than racial minorities (relative risk [RR], 1.13; 95% confidence interval [CI], 1.10-1.17), and privately insured individuals were more likely to receive lobectomy than those with Medicaid or Medicare (RR, 1.28; 95% CI, 1.25-1.30). Conclusion: Despite Class I evidence and subsequent practice guidelines, the utilization of lobectomy has not increased from 1990 to 2008. Surgery continues to be heavily underutilized as a treatment for epilepsy, with significant disparities by race and insurance coverage. Patients who are medically refractory after failing 2 antiepileptic medications should be referred to a comprehensive epilepsy center for surgical evaluation. To examine national time trends of resective surgery for the treatment of medically refractory epilepsy before and after Class I evidence demonstrating its efficacy and subsequent practice guidelines recommending early surgical evaluation. We performed a population-based cohort study with time trends of patients admitted to US hospitals for medically refractory focal epilepsy between 1990 and 2008 who did or did not undergo lobectomy, as reported in the Nationwide Inpatient Sample. Weighted data revealed 112,026 hospitalizations for medically refractory focal epilepsy and 6,653 resective surgeries (lobectomies and partial lobectomies) from 1990 to 2008. A trend of increasing hospitalizations over time was not accompanied by an increase in surgeries, producing an overall trend of decreasing surgery rates (F = 13.6, p < 0.01). Factors associated with this trend included a decrease in epilepsy hospitalizations at the highest-volume epilepsy centers, and increased hospitalizations to lower-volume hospitals that were found to be less likely to perform surgery. White patients were more likely to have surgery than racial minorities (relative risk [RR], 1.13; 95% confidence interval [CI], 1.10-1.17), and privately insured individuals were more likely to receive lobectomy than those with Medicaid or Medicare (RR, 1.28; 95% CI, 1.25-1.30). Despite Class I evidence and subsequent practice guidelines, the utilization of lobectomy has not increased from 1990 to 2008. Surgery continues to be heavily underutilized as a treatment for epilepsy, with significant disparities by race and insurance coverage. Patients who are medically refractory after failing 2 antiepileptic medications should be referred to a comprehensive epilepsy center for surgical evaluation. |
Author | CHANG, E. F OUYANG, D GARCIA, P. A ENGLOT, D. J BARBARO, N. M |
Author_xml | – sequence: 1 givenname: D. J surname: ENGLOT fullname: ENGLOT, D. J organization: UCSF Epilepsy Center, United States – sequence: 2 givenname: D surname: OUYANG fullname: OUYANG, D organization: UCSF Epilepsy Center, United States – sequence: 3 givenname: P. A surname: GARCIA fullname: GARCIA, P. A organization: Department of Neurology, University of California, San Francisco, United States – sequence: 4 givenname: N. M surname: BARBARO fullname: BARBARO, N. M organization: UCSF Epilepsy Center, United States – sequence: 5 givenname: E. F surname: CHANG fullname: CHANG, E. F organization: UCSF Epilepsy Center, United States |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26425341$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22442428$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkc1u1DAUhS1URKeFN0AoGyQWTbk_dmJvkKqqBaQRLKCCneWxnTYo4wx2Bml2vAQvyJMQ1KH8rFjdxfnO0b33HImDNKYoxGOEUySk5x_eLE9hBciRUZOC0EZ3TyxQUVM3TB8PxAKAdM261YfiqJRPALPYmgfikEhKkqQXwlxs-iFuyq4q23wd866ackyhVH2qpptYXaV-iqF6N7kplpMKjYHvX78RgH4o7nduKPHRfh6Lq8uL9-ev6uXbl6_Pz5a1ly1ONQbsEBSzcYE9OqWb2LFfkeMQlGQTGr2ad6ROI2vtlXdKtb41XTDBaM_H4sVt7ma7WsfgY5qyG-wm92uXd3Z0vf1bSf2NvR6_WGaSTDAHPNsH5PHzNpbJrvvi4zC4FMdtsQgoEXSD9B8okJLzG_WMylvU57GUHLu7jRDsz4LsXJD9t6DZ9uTPa-5MvxqZgad7wBXvhi675Pvym2skKZbIPwAq45sQ |
CODEN | NEURAI |
CitedBy_id | crossref_primary_10_1111_epi_17923 crossref_primary_10_1016_j_yebeh_2018_12_023 crossref_primary_10_1007_s10072_020_05016_x crossref_primary_10_1002_epi4_12919 crossref_primary_10_1016_j_clineuro_2017_05_001 crossref_primary_10_5698_1535_7511_16_4_232 crossref_primary_10_1007_s00381_013_2168_7 crossref_primary_10_1111_epi_12912 crossref_primary_10_1016_j_yebeh_2014_12_027 crossref_primary_10_1016_j_seizure_2022_11_012 crossref_primary_10_1097_WCO_0000000000000067 crossref_primary_10_1016_j_yebeh_2024_109707 crossref_primary_10_1016_j_eplepsyres_2016_05_001 crossref_primary_10_1016_j_eplepsyres_2018_02_012 crossref_primary_10_1016_j_nic_2020_02_002 crossref_primary_10_1016_j_yebeh_2016_12_033 crossref_primary_10_1016_j_wneu_2018_10_043 crossref_primary_10_1016_j_yebeh_2021_107910 crossref_primary_10_1016_j_clineuro_2017_10_038 crossref_primary_10_1016_j_praneu_2014_10_005 crossref_primary_10_1016_j_yebeh_2013_06_020 crossref_primary_10_1016_j_eplepsyres_2015_07_007 crossref_primary_10_1007_s10143_014_0527_9 crossref_primary_10_23736_S0390_5616_18_04448_X crossref_primary_10_2176_nmc_st_2021_0230 crossref_primary_10_2214_AJR_22_27925 crossref_primary_10_1109_TBME_2018_2797919 crossref_primary_10_1111_ene_12322 crossref_primary_10_1186_s41983_020_00168_1 crossref_primary_10_1016_j_eplepsyres_2018_10_006 crossref_primary_10_1177_2329048X211012544 crossref_primary_10_1016_j_nec_2014_11_015 crossref_primary_10_3171_2013_5_PEDS12526 crossref_primary_10_1227_NEU_0000000000001799 crossref_primary_10_1111_epi_14627 crossref_primary_10_1016_j_spen_2021_100916 crossref_primary_10_25259_SNI_824_2021 crossref_primary_10_1016_j_clinph_2014_04_017 crossref_primary_10_1016_j_nec_2015_08_004 crossref_primary_10_1016_j_yebeh_2021_108227 crossref_primary_10_3171_2019_4_JNS183235 crossref_primary_10_1212_WNL_0b013e3182a55fb9 crossref_primary_10_1016_S1474_4422_15_70011_6 crossref_primary_10_1111_epi_12791 crossref_primary_10_1177_1179573520935031 crossref_primary_10_1111_ane_13393 crossref_primary_10_1016_j_yebeh_2017_03_017 crossref_primary_10_3171_2019_9_JNS191769 crossref_primary_10_1111_epi_13766 crossref_primary_10_1016_S1474_4422_14_70156_5 crossref_primary_10_1016_j_ncl_2020_09_010 crossref_primary_10_1016_j_jocn_2016_12_002 crossref_primary_10_1111_epi_14045 crossref_primary_10_1192_bjpo_bp_115_002345 crossref_primary_10_1002_epi4_12789 crossref_primary_10_1227_neu_0000000000002811 crossref_primary_10_1227_neu_0000000000001961 crossref_primary_10_1016_j_clineuro_2024_108151 crossref_primary_10_1212_WNL_0000000000012514 crossref_primary_10_1016_j_yebeh_2017_08_010 crossref_primary_10_1016_j_aorn_2017_09_003 crossref_primary_10_1080_14737175_2019_1650642 crossref_primary_10_1016_j_yebeh_2021_107837 crossref_primary_10_1016_j_wneu_2017_01_093 crossref_primary_10_1007_s00330_020_07645_4 crossref_primary_10_1016_j_seizure_2021_07_007 crossref_primary_10_3171_2021_7_JNS21123 crossref_primary_10_1002_epi4_12541 crossref_primary_10_1212_01_CON_0000431397_61970_2b crossref_primary_10_3389_fneur_2014_00244 crossref_primary_10_1111_epi_16572 crossref_primary_10_1136_jnnp_2012_304038 crossref_primary_10_1016_j_yebeh_2018_01_030 crossref_primary_10_46563_2686_8997_2021_2_1_29_37 crossref_primary_10_1016_j_clineuro_2013_09_035 crossref_primary_10_3171_2020_6_JNS20732 crossref_primary_10_1016_S0140_6736_18_32596_0 crossref_primary_10_3171_2013_5_PEDS1336 crossref_primary_10_1007_s10143_016_0725_8 crossref_primary_10_1212_WNL_0000000000005776 crossref_primary_10_1002_ana_24635 crossref_primary_10_1002_epi4_12099 crossref_primary_10_1016_j_jns_2019_06_026 crossref_primary_10_1080_14737175_2020_1713100 crossref_primary_10_1002_epi4_12650 crossref_primary_10_1111_ane_13008 crossref_primary_10_1007_s00415_017_8394_2 crossref_primary_10_1016_j_jocn_2014_12_002 crossref_primary_10_1212_WNL_0b013e318250d86b crossref_primary_10_1111_epi_16320 crossref_primary_10_1136_jnnp_2017_316833 crossref_primary_10_1016_j_neuropharm_2019_107762 crossref_primary_10_1016_j_ncl_2022_03_010 crossref_primary_10_1016_j_ncl_2022_03_012 crossref_primary_10_1111_epi_13058 crossref_primary_10_1016_j_seizure_2020_05_013 crossref_primary_10_1016_j_yebeh_2021_107853 crossref_primary_10_1016_j_seizure_2021_02_002 crossref_primary_10_1212_WNL_0000000000000750 crossref_primary_10_1038_nrneurol_2012_181 crossref_primary_10_1002_epi4_12874 crossref_primary_10_1016_j_wneu_2017_05_004 crossref_primary_10_1007_s40265_015_0395_9 crossref_primary_10_1016_j_seizure_2018_11_007 crossref_primary_10_1007_s00381_017_3639_z crossref_primary_10_3171_2018_12_PEDS18350 crossref_primary_10_1016_j_wneu_2015_05_009 crossref_primary_10_1111_epi_16436 crossref_primary_10_1212_WNL_0000000000013130 crossref_primary_10_1212_WNL_0000000000000740 crossref_primary_10_1007_s10309_023_00571_7 crossref_primary_10_1016_j_eplepsyres_2021_106725 crossref_primary_10_1093_neuros_nyz556 crossref_primary_10_1212_WNL_0000000000002249 crossref_primary_10_1111_epi_16423 crossref_primary_10_1177_0883073820966935 crossref_primary_10_1016_j_seizure_2015_01_005 crossref_primary_10_1111_epi_12988 crossref_primary_10_1227_NEU_0000000000000286 crossref_primary_10_1016_j_ultrasmedbio_2020_01_008 crossref_primary_10_1001_jamaneurol_2024_0551 crossref_primary_10_1016_j_ncl_2021_04_001 crossref_primary_10_1016_S0140_6736_14_60456_6 crossref_primary_10_1016_j_yebeh_2015_04_033 crossref_primary_10_1016_S1474_4422_17_30429_5 crossref_primary_10_3171_2014_8_GKS141608 crossref_primary_10_1227_ons_0000000000000230 crossref_primary_10_1227_NEU_0000000000001165 crossref_primary_10_1111_dmcn_13292 crossref_primary_10_1111_epi_12974 crossref_primary_10_1016_j_clinph_2015_05_009 crossref_primary_10_1016_j_seizure_2013_02_015 crossref_primary_10_1111_epi_16414 crossref_primary_10_1097_WCO_0b013e32835ef345 crossref_primary_10_1016_j_eplepsyres_2012_07_016 crossref_primary_10_1016_j_eplepsyres_2015_05_007 crossref_primary_10_1212_CPJ_0000000000000490 crossref_primary_10_1007_s00381_024_06319_6 crossref_primary_10_1111_epi_12979 crossref_primary_10_5698_1535_7597_13_5_198 crossref_primary_10_1016_j_yebeh_2014_06_013 crossref_primary_10_1212_CPJ_0000000000000011 crossref_primary_10_1212_01_wnl_0000419803_22062_59 crossref_primary_10_1016_j_seizure_2019_05_004 crossref_primary_10_1007_s11910_012_0287_2 crossref_primary_10_1002_epi4_12965 crossref_primary_10_1016_j_yebeh_2022_108925 crossref_primary_10_1111_epi_18030 crossref_primary_10_1016_j_yebeh_2022_108923 crossref_primary_10_1016_S1474_4422_14_70325_4 crossref_primary_10_5698_1535_7597_16_1_21 crossref_primary_10_3390_brainsci8020022 crossref_primary_10_3171_2018_1_FOCUS17683 crossref_primary_10_1111_epi_16637 crossref_primary_10_1016_j_yebeh_2017_05_026 crossref_primary_10_1111_epi_13489 crossref_primary_10_3171_2016_12_JNS162096 crossref_primary_10_1016_j_wneu_2016_12_074 crossref_primary_10_1111_epi_12719 crossref_primary_10_1177_1535759720941061 crossref_primary_10_1111_epi_17172 crossref_primary_10_3171_CASE22210 crossref_primary_10_1111_epi_12957 crossref_primary_10_1212_01_CON_0000431398_69594_97 crossref_primary_10_3171_2014_1_JNS131694 crossref_primary_10_1111_ene_12358 crossref_primary_10_5694_mja17_00951 crossref_primary_10_1212_CPJ_0000000000000628 crossref_primary_10_1212_WNL_0000000000005021 crossref_primary_10_1212_CPJ_0000000000000625 crossref_primary_10_1212_WNL_0000000000200569 crossref_primary_10_1016_j_yebeh_2012_05_017 crossref_primary_10_1016_j_ebr_2022_100527 crossref_primary_10_1111_epi_12148 crossref_primary_10_1111_epi_13116 crossref_primary_10_1002_hbm_22628 crossref_primary_10_1016_j_neuron_2015_03_037 crossref_primary_10_1016_j_yebeh_2021_108529 crossref_primary_10_1212_WNL_0000000000003407 crossref_primary_10_1111_ane_13418 crossref_primary_10_1212_CPJ_0000000000200259 crossref_primary_10_1016_j_yebeh_2021_108403 crossref_primary_10_3171_2022_1_JNS212613 crossref_primary_10_1016_j_eplepsyres_2020_106473 crossref_primary_10_7887_jcns_23_627 crossref_primary_10_1016_j_wneu_2018_09_079 crossref_primary_10_1016_j_clineuro_2020_106416 crossref_primary_10_1055_s_0042_1760105 crossref_primary_10_1016_j_eplepsyres_2019_106252 crossref_primary_10_12688_f1000research_17714_1 crossref_primary_10_3171_2020_1_FOCUS19935 crossref_primary_10_1016_j_neurom_2023_11_007 crossref_primary_10_1016_j_yebeh_2017_12_041 crossref_primary_10_1016_j_wneu_2018_11_170 crossref_primary_10_1016_S1474_4422_16_30127_2 crossref_primary_10_1002_ana_25205 crossref_primary_10_1016_j_eplepsyres_2016_01_009 crossref_primary_10_1016_j_pcl_2021_04_016 crossref_primary_10_1016_j_nec_2017_06_001 crossref_primary_10_3171_2012_9_JNS12776 crossref_primary_10_1111_epi_17499 crossref_primary_10_2176_nmc_ra_2014_0414 crossref_primary_10_1016_j_eplepsyres_2015_09_012 crossref_primary_10_1016_j_clineuro_2018_01_017 crossref_primary_10_7759_cureus_45996 crossref_primary_10_1212_CPJ_0000000000000048 crossref_primary_10_1039_C9AY02582K |
Cites_doi | 10.1212/WNL.0b013e3181eee510 10.1097/SLA.0b013e3181a77cb3 10.1016/j.eplepsyres.2010.11.005 10.1016/S0079-6123(09)17711-7 10.1056/NEJM200002033420503 10.1111/j.1528-1167.2006.00569.x 10.1093/brain/awl364 10.1001/jama.2008.771 10.1111/j.1528-1167.2008.01898.x 10.1001/archneurol.2010.86 10.1001/jama.2008.756 10.1097/WCO.0b013e32834479a7 10.3171/2011.7.JNS11977 10.1227/01.NEU.0000065129.25359.EE 10.1212/01.WNL.0000055086.35806.2D 10.3171/jns.2000.92.1.0024 10.1111/j.1528-1167.2010.02648.x 10.1111/j.1528-1167.2009.02237.x 10.1016/j.yebeh.2006.05.011 10.1684/epd.2010.0303 10.3171/2008.12.JNS081112 10.1212/WNL.0b013e3181eee457 10.1111/j.1528-1167.2006.00702.x 10.1056/NEJM200108023450510 10.1016/S1474-4422(08)70109-1 10.1001/jama.2010.885 10.1111/j.1528-1167.2007.01136.x 10.1046/j.1528-1157.42.s6.1.x 10.1017/S1092852900008488 10.1056/NEJM200108023450501 10.1002/ana.22142 10.1001/archneurol.2011.7 10.1111/j.1528-1167.2009.02282.x |
ContentType | Journal Article |
Copyright | 2015 INIST-CNRS Copyright © 2012 by AAN Enterprises, Inc. 2012 AAN Enterprises, Inc. |
Copyright_xml | – notice: 2015 INIST-CNRS – notice: Copyright © 2012 by AAN Enterprises, Inc. 2012 AAN Enterprises, Inc. |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 7TK 5PM |
DOI | 10.1212/WNL.0b013e318250d7ea |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic Neurosciences Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic Neurosciences Abstracts |
DatabaseTitleList | MEDLINE - Academic Neurosciences Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1526-632X |
EndPage | 1206 |
ExternalDocumentID | 10_1212_WNL_0b013e318250d7ea 22442428 26425341 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | United States North America America |
GeographicLocations_xml | – name: United States |
GroupedDBID | --- -~X .55 .GJ .XZ .Z2 01R 08R 0R~ 123 1CY 1J1 1KJ 29N 2WC 354 3PY 4Q1 4Q2 4Q3 53G 5RE 5VS 6PF 77Y A9M AAAXR AAGIX AAHPQ AAJCS AAMOA AAMTA AAPBV AAQKA AAQQT AARTV AASOK AASXQ AAUGY AAWTL AAXQO AAYEP AAYOK ABBLC ABIVO ABOCM ACCJW ACDDN ACGFS ACILI ACOAL ACWRI ADGGA ADNKB AE6 AEBDS AENEX AFDTB AFFNX AFUWQ AGINI AHOMT AHVBC AIJEX AKALU AKULP ALMA_UNASSIGNED_HOLDINGS AMJPA AMKUR AMNEI AOHHW AWKKM BOYCO BQLVK BYPQX C45 CS3 DIWNM DU5 E.X EBS EJD EX3 F2K F2L F2M F2N F5P FA8 FCALG FW0 GQDEL HZ~ H~9 IKYAY IN~ IPNFZ IQODW J5H JF7 KD2 KMI L-C L7B N4W N9A NEJ N~7 N~B O9- OAG OAH OBH ODMTH OHH OHT OHYEH OJAPA OL1 OLB OLH OLU OLV OLW OLY OLZ OPX OVD OVDNE OVIDH OVLEI OWU OWV OWW OWX OWY OWZ OXXIT P2P RHI RIG RLZ RXW SJN TAE TEORI TWZ UDS V2I VVN W3M WH7 WOQ WOW X7M XJT XOL XSW XXN XYM XYN YBU YCJ YFH YYP ZA5 ZGI ZKB ZXP ~9M AAIQE AASCR ABJNI ABVCZ ACLDA ACXJB AFEXH AHQNM AKWKN CGR CUY CVF ECM EIF ERAAH NPM AAYXX CITATION 7X8 7TK 5PM |
ID | FETCH-LOGICAL-c471t-1d1f105339ad3c1a586ef3cb2a3dd5439d68b3872f81388c5ca557c79fd9d98c3 |
ISSN | 0028-3878 |
IngestDate | Tue Sep 17 21:22:46 EDT 2024 Fri Oct 25 05:05:15 EDT 2024 Fri Oct 25 11:41:46 EDT 2024 Thu Nov 21 21:14:09 EST 2024 Tue Oct 15 23:44:55 EDT 2024 Sun Oct 22 16:06:01 EDT 2023 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 16 |
Keywords | Nervous system diseases Surgery Epilepsy Central nervous system disease Cerebral disorder |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c471t-1d1f105339ad3c1a586ef3cb2a3dd5439d68b3872f81388c5ca557c79fd9d98c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 Study funding: Supported in part by the Clinical and Translational Science Institute at UCSF. Statistical support was provided by Dr. Cheng at the Clinical and Translational Science Institute Consultations Services at UCSF. |
OpenAccessLink | https://europepmc.org/articles/pmc3324320?pdf=render |
PMID | 22442428 |
PQID | 1002540158 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3324320 proquest_miscellaneous_1014108612 proquest_miscellaneous_1002540158 crossref_primary_10_1212_WNL_0b013e318250d7ea pubmed_primary_22442428 pascalfrancis_primary_26425341 |
PublicationCentury | 2000 |
PublicationDate | 2012-04-17 |
PublicationDateYYYYMMDD | 2012-04-17 |
PublicationDate_xml | – month: 04 year: 2012 text: 2012-04-17 day: 17 |
PublicationDecade | 2010 |
PublicationPlace | Hagerstown, MD |
PublicationPlace_xml | – name: Hagerstown, MD – name: United States |
PublicationTitle | Neurology |
PublicationTitleAlternate | Neurology |
PublicationYear | 2012 |
Publisher | Lippincott Williams & Wilkins |
Publisher_xml | – name: Lippincott Williams & Wilkins |
References | 16839821 - Epilepsy Behav. 2006 Sep;9(2):243-64 21177075 - Epilepsy Res. 2011 Feb;93(2-3):115-9 11902321 - Epilepsia. 2001;42 Suppl 6:4-8 20733142 - Neurology. 2010 Aug 24;75(8):678-9 21838505 - J Neurosurg. 2011 Dec;115(6):1248-55 10616078 - J Neurosurg. 2000 Jan;92(1):24-30 11484695 - N Engl J Med. 2001 Aug 2;345(5):365-7 19702735 - Epilepsia. 2009 Sep;50 Suppl 8:57-62 17209228 - Brain. 2007 Feb;130(Pt 2):574-84 19575575 - J Neurosurg. 2010 Jan;112(1):168-85 19818900 - Prog Brain Res. 2009;177:147-70 20457957 - Arch Neurol. 2010 May;67(5):577-83 11484687 - N Engl J Med. 2001 Aug 2;345(5):311-8 17105474 - Epilepsia. 2006;47 Suppl 2:96-8 14758935 - J Neurosurg. 2004 Feb;100(2 Suppl Pediatrics):90-7 19561457 - Ann Surg. 2009 Jul;250(1):159-65 20733145 - Neurology. 2010 Aug 24;75(8):699-704 19732134 - Epilepsia. 2009 Oct;50(10):2285-95 14999168 - CNS Spectr. 2004 Feb;9(2):120-2, 126-32 16822241 - Epilepsia. 2006 Jun;47(6):952-9 12601090 - Neurology. 2003 Feb 25;60(4):538-47 22442432 - Neurology. 2012 Apr 17;78(16):1194-5 10660394 - N Engl J Med. 2000 Feb 3;342(5):314-9 12762870 - Neurosurgery. 2003 Jun;52(6):1251-61; discussion 1261-2 16397445 - Rev Neurol Dis. 2004 Winter;1(1):2-9 20606149 - JAMA. 2010 Jul 7;304(1):53-60 19050199 - JAMA. 2008 Dec 3;300(21):2548-50 21301338 - Curr Opin Neurol. 2011 Apr;24(2):159-64 19050193 - JAMA. 2008 Dec 3;300(21):2497-505 20976764 - Ann Neurol. 2010 Oct;68(4):424-34 20561026 - Epilepsia. 2010 Nov;51(11):2322-33 21320984 - Arch Neurol. 2011 Jun;68(6):725-9 19054413 - Epilepsia. 2009 May;50(5):1040-50 12088294 - Eff Clin Pract. 2002 May-Jun;5(3):143-51 17521343 - Epilepsia. 2007 Jul;48(7):1303-7 20211804 - Epileptic Disord. 2010 Mar;12(1):3-15 22987746 - Neurology. 2012 Sep 18;79(12):1302; author reply 1302 18485316 - Lancet Neurol. 2008 Jun;7(6):525-37 Engel J (e_1_3_7_10_2) 1993 Smith ER (e_1_3_7_34_2) 2004; 100 e_1_3_7_40_2 e_1_3_7_20_2 e_1_3_7_22_2 e_1_3_7_21_2 e_1_3_7_24_2 e_1_3_7_23_2 e_1_3_7_26_2 e_1_3_7_25_2 e_1_3_7_28_2 e_1_3_7_27_2 e_1_3_7_29_2 e_1_3_7_9_2 e_1_3_7_31_2 Steiner C (e_1_3_7_14_2) 2002; 5 e_1_3_7_30_2 e_1_3_7_33_2 e_1_3_7_11_2 e_1_3_7_32_2 e_1_3_7_12_2 e_1_3_7_35_2 e_1_3_7_13_2 e_1_3_7_37_2 e_1_3_7_15_2 e_1_3_7_36_2 e_1_3_7_16_2 e_1_3_7_39_2 e_1_3_7_17_2 e_1_3_7_38_2 e_1_3_7_18_2 Engel J (e_1_3_7_3_2) 1987 e_1_3_7_19_2 e_1_3_7_4_2 Devinsky O (e_1_3_7_2_2) 2004; 1 e_1_3_7_6_2 e_1_3_7_5_2 e_1_3_7_8_2 e_1_3_7_7_2 |
References_xml | – ident: e_1_3_7_25_2 doi: 10.1212/WNL.0b013e3181eee510 – ident: e_1_3_7_37_2 doi: 10.1097/SLA.0b013e3181a77cb3 – ident: e_1_3_7_20_2 doi: 10.1016/j.eplepsyres.2010.11.005 – ident: e_1_3_7_27_2 doi: 10.1016/S0079-6123(09)17711-7 – ident: e_1_3_7_26_2 doi: 10.1056/NEJM200002033420503 – ident: e_1_3_7_33_2 doi: 10.1111/j.1528-1167.2006.00569.x – ident: e_1_3_7_5_2 doi: 10.1093/brain/awl364 – ident: e_1_3_7_11_2 doi: 10.1001/jama.2008.771 – ident: e_1_3_7_40_2 doi: 10.1111/j.1528-1167.2008.01898.x – ident: e_1_3_7_15_2 doi: 10.1001/archneurol.2010.86 – ident: e_1_3_7_6_2 doi: 10.1001/jama.2008.756 – ident: e_1_3_7_19_2 doi: 10.1097/WCO.0b013e32834479a7 – ident: e_1_3_7_22_2 doi: 10.3171/2011.7.JNS11977 – ident: e_1_3_7_35_2 doi: 10.1227/01.NEU.0000065129.25359.EE – volume: 1 start-page: 2 year: 2004 ident: e_1_3_7_2_2 article-title: Diagnosis and treatment of temporal lobe epilepsy publication-title: Rev Neurol Dis contributor: fullname: Devinsky O – ident: e_1_3_7_13_2 doi: 10.1212/01.WNL.0000055086.35806.2D – volume: 100 start-page: 90 year: 2004 ident: e_1_3_7_34_2 article-title: In-hospital mortality rates after ventriculoperitoneal shunt procedures in the United States, 1998 to 2000: relation to hospital and surgeon volume of care publication-title: J Neurosurg contributor: fullname: Smith ER – ident: e_1_3_7_31_2 doi: 10.3171/jns.2000.92.1.0024 – ident: e_1_3_7_32_2 doi: 10.1111/j.1528-1167.2010.02648.x – start-page: 553 volume-title: Surgical Treatment of the Epilepsies year: 1987 ident: e_1_3_7_3_2 contributor: fullname: Engel J – ident: e_1_3_7_7_2 doi: 10.1111/j.1528-1167.2009.02237.x – start-page: 23 volume-title: Surgical Treatment of the Epilepsies year: 1993 ident: e_1_3_7_10_2 contributor: fullname: Engel J – ident: e_1_3_7_38_2 doi: 10.1016/j.yebeh.2006.05.011 – ident: e_1_3_7_18_2 doi: 10.1684/epd.2010.0303 – ident: e_1_3_7_23_2 doi: 10.3171/2008.12.JNS081112 – ident: e_1_3_7_24_2 – ident: e_1_3_7_8_2 doi: 10.1212/WNL.0b013e3181eee457 – ident: e_1_3_7_28_2 doi: 10.1111/j.1528-1167.2006.00702.x – ident: e_1_3_7_9_2 doi: 10.1056/NEJM200108023450510 – ident: e_1_3_7_4_2 doi: 10.1016/S1474-4422(08)70109-1 – volume: 5 start-page: 143 year: 2002 ident: e_1_3_7_14_2 article-title: The healthcare cost and utilization project: an overview publication-title: Eff Clin Pract contributor: fullname: Steiner C – ident: e_1_3_7_36_2 doi: 10.1001/jama.2010.885 – ident: e_1_3_7_21_2 doi: 10.1111/j.1528-1167.2007.01136.x – ident: e_1_3_7_30_2 doi: 10.1046/j.1528-1157.42.s6.1.x – ident: e_1_3_7_29_2 doi: 10.1017/S1092852900008488 – ident: e_1_3_7_12_2 doi: 10.1056/NEJM200108023450501 – ident: e_1_3_7_17_2 doi: 10.1002/ana.22142 – ident: e_1_3_7_16_2 doi: 10.1001/archneurol.2011.7 – ident: e_1_3_7_39_2 doi: 10.1111/j.1528-1167.2009.02282.x |
SSID | ssj0015279 |
Score | 2.5437505 |
Snippet | To examine national time trends of resective surgery for the treatment of medically refractory epilepsy before and after Class I evidence demonstrating its... OBJECTIVETo examine national time trends of resective surgery for the treatment of medically refractory epilepsy before and after Class I evidence... Objective: To examine national time trends of resective surgery for the treatment of medically refractory epilepsy before and after Class I evidence... |
SourceID | pubmedcentral proquest crossref pubmed pascalfrancis |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 1200 |
SubjectTerms | Adult Anterior Temporal Lobectomy - trends Biological and medical sciences Data processing Drug Resistance Epilepsy Epilepsy - surgery European Continental Ancestry Group - statistics & numerical data Female Guideline Adherence - trends Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy Hospitalization - trends Hospitals Humans Insurance, Hospitalization - statistics & numerical data Male Medicaid - statistics & numerical data Medical sciences Medicare - statistics & numerical data Minority Groups - statistics & numerical data Nervous system (semeiology, syndromes) Neurology Practice Guidelines as Topic Races Risk assessment Surgery United States |
Title | Epilepsy surgery trends in the United States, 1990―2008 |
URI | https://www.ncbi.nlm.nih.gov/pubmed/22442428 https://search.proquest.com/docview/1002540158 https://search.proquest.com/docview/1014108612 https://pubmed.ncbi.nlm.nih.gov/PMC3324320 |
Volume | 78 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZokRASQrxZHpWRuIFhbcexc0Q0pUJLitSt6C1ybEf0kl2R7qH_nnHsPLasUDlwiTbexNmdLx5_M54ZI_TWZdzZlFpCDdMksdqQSsxrOAVzpJqnWaV9cvLxqSzO1WGe5OPGf2Pbf0Ua2gBrnzn7D2gPnUIDfAbM4Qiow_FGuOdrGOfr9updGxKefSh5jHr9g2N6-VKYKPxfU1Oa2pXsmPrbfbbvqtPXh-NC0snmKnqbh7DhL35roo6Pfp96Sf2aRueTLaL3NfoZfMBGQkJa5QcXdSNLScq73c8H5SnV9CWZqkIaSpD20yqcpjtVNsydINMfxWL0yQIts9JNpqh-Wb44KY_OFotymZ8v99BtBsrF67bTr8WwciSgMaZIQs8fd_W7RUHurXULo6EO25jssjOuh8tO-MfyAbofDQf8KSD-EN1yzSN051sMjXiMZA88jsDjADy-aDAAjwPwOAD_Hg-wP0FnR_ny8zGJu2IQA0TiklBLa-ozqDNtuaFaqNTV3FRMc2sF8EubqooryWpFuVJGGC2ENDKrbWYzZfhTtN-sGvccYWM5EGCdJob6kgiVMkkyZ0CbslryhLkZIr2gynUoflJ6oxEEW4Jgy-uCnaGDLWkONwHrZgL40gy96cVbghrza1O6catN60tnMzAeqFB_u8YHJSvg5DP0LEAyPgFoKrBNuFtugTVc4Muob3_TXPzsyqlzsCk4m7-4wW97ie6OQ-MV2r_8tXGv0V5rNwfdW_gb-7eJ0Q |
link.rule.ids | 230,315,782,786,887,27933,27934 |
linkProvider | Multiple Vendors |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Epilepsy+surgery+trends+in+the+United+States%2C+1990-2008&rft.jtitle=Neurology&rft.au=Englot%2C+D+J&rft.au=Ouyang%2C+D&rft.au=Garcia%2C+P+A&rft.au=Barbaro%2C+N+M&rft.date=2012-04-17&rft.eissn=1526-632X&rft.volume=78&rft.issue=16&rft.spage=1200&rft.epage=1206&rft_id=info:doi/10.1212%2FWNL.0b013e318250d7ea&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0028-3878&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0028-3878&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0028-3878&client=summon |